[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming

R Mattioli, A Ilari, B Colotti, L Mosca, F Fazi… - Molecular Aspects of …, 2023 - Elsevier
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …

Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics

H Tiwari, N Rai, S Singh, P Gupta, A Verma, AK Singh… - Bioengineering, 2023 - mdpi.com
Nano-oncology is a branch of biomedical research and engineering that focuses on using
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …

Understanding cancer's defense against topoisomerase-active drugs: A comprehensive review

NK Sharma, A Bahot, G Sekar, M Bansode, K Khunteta… - Cancers, 2024 - mdpi.com
Simple Summary Increasing number of cancer patients and significant mortality among
these patients are attributed to many factors including anticancer drug resistance. Among a …

[PDF][PDF] Kajal; Salvi, P.; Singh, SK; Gautam, V

H Tiwari, N Rai - … in Nanomaterials-Based Targeted Drug Delivery …, 2023 - researchgate.net
Nano-oncology is a branch of biomedical research and engineering that focuses on using
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …

Non-coding RNAs in gynecologic cancer

A Solati, S Thvimi, SH Khatami, Z Shabaninejad… - Clinica Chimica …, 2023 - Elsevier
The term “gynecologic cancer” pertains to neoplasms impacting the reproductive tissues and
organs of women encompassing the endometrium, vagina, cervix, uterus, vulva, and …

Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics

N Bano, KM Kainat, MI Ansari, A Pal… - Journal of …, 2024 - Taylor & Francis
Acquired chemoresistance remains a significant challenge in the clinics as most of the
treated cancers eventually emerge as hard-to-treat phenotypes. Therefore, identifying …

Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells

J Bernasinska-Slomczewska, P Hikisz, A Pieniazek… - Molecules, 2024 - mdpi.com
Breast cancer is a major health concern and the leading cause of death among women
worldwide. Standard treatment often involves surgery, radiotherapy, and chemotherapy, but …

[HTML][HTML] Protective effect of low-dose radiation on doxorubicin-induced brain injury in mice

Y Gao, J Dong, M Chen, T Wang, Z Yang, K He… - Archives of Biochemistry …, 2022 - Elsevier
Background To investigate the protective effect of low-dose radiation (LDR) on brain injury in
mice induced by doxorubicin (DOX). Methods Sixty female BALB/C mice were randomly …

Interpretable machine learning models to predict the resistance of breast cancer patients to doxorubicin from their microRNA profiles

AZ Ogunleye, C Piyawajanusorn… - Advanced …, 2022 - Wiley Online Library
Doxorubicin is a common treatment for breast cancer. However, not all patients respond to
this drug, which sometimes causes life‐threatening side effects. Accurately anticipating …

[HTML][HTML] Overexpression of miR-490-5p/miR-490-3p potentially induces IL-17-Producing T cells in patients with breast cancer

F Seif, H Vaseghi, M Ariana, SM Ganji… - European Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: Breast cancer (BC) is the most prevalent female cancer globally and this is also
true in Iranian women. Alteration in circulating microRNAs affects the fate of immune cells …